Phenoxybenzamine in neurogenic bladder dysfunction. II. Clinical considerations.
D000328:Adult; D006801:Humans; D008297:Male; D008875:Middle Aged; D009433:Neural Inhibition / Q000187:drug effects*; D010275:Parasympathetic Nervous System / Q000187:drug effects / Q000503:physiopathology; D010643:Phenoxybenzamine / Q000627:therapeutic use*; D011312:Pressure; D013564:Sympathetic Nervous System / Q000187:drug effects* / Q000503:physiopathology*; D014521:Urethra / Q000502:physiology; D001743:Urinary Bladder / Q000294:innervation*; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy* / Q000503:physiopathology*; D014567:Urography
D010643:Phenoxybenzamine